Miglustat
Products in Health Canada’s databases that list Miglustat as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 3
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 13
- Products in all
- 3
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| OPFOLDA (65 MG) | 02556812 | Marketed | Amicus Therapeutics Canada Inc. | |
| SANDOZ MIGLUSTAT (100 MG) | 02456257 | Marketed | Sandoz Canada Inc. | |
| ZAVESCA (100 MG) | 02250519 | Marketed | Janssen Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- SANDOZ MIGLUSTATJune 12, 2026 · NOC 37705
- OPFOLDAOctober 29, 2025 · NOC 36279
- OPFOLDAApril 10, 2025 · NOC 35159
- SANDOZ MIGLUSTATAugust 24, 2022 · NOC 28825
- ZAVESCAMarch 2, 2022 · NOC 27694
- ZAVESCAJanuary 18, 2022 · NOC 27418
- SANDOZ MIGLUSTATJanuary 13, 2021 · NOC 24999
- SANDOZ MIGLUSTATApril 21, 2020 · NOC 23493
- ZAVESCASeptember 12, 2019 · NOC 22640
- ZAVESCANovember 23, 2018 · NOC 21563
- SANDOZ MIGLUSTATJuly 12, 2016 · NOC 18264
- ZAVESCAMarch 4, 2010 · NOC 11126
- ZAVESCAMarch 31, 2004 · NOC 292